Egypt Ventricular Assist Device Market

The Egypt Ventricular Assist Device Market touched XX million in 2017, and is projected to reach USD XX million by 2025, growing at a CAGR of 9.0 % during 2018-2025.

Egypt Ventricular Assist Device Market Revenue, 2018–2025 (USD Million)

Source: GMI Research

The key factors fuelling the growth of the market are rising number of patients waiting for heart transplantation, increase in heart failures cases and shortage of appropriate donor organs propels the demand for alternative approaches particularly VADs.

The highest growth rate is predicted to be exhibited by Bridge-to-recovery (BTR) Therapy segment during the forecast period due to increasing government funding coupled with ongoing research activities in this area support the growth of ventricular assist devices. However, Bridge-to-transplant (BTT) Therapy segment is expected to hold maximum share in the market during the forecast period.

Implantable design segment is possessed to lead the market during 2018-2025
The Implantable design segment possesses promising growth potential and in the next few years is expected to show signs of improvement, driven by factors like lower rate of thrombosis and increasing concern towards health issues. Transcutaneous design type is predicted to have the highest growth rate as the it is based on the latest technology with no thrombosis rate.

The companies are focusing on product launches, research and development activities to gain the competitive advantage in Egypt Ventricular Assist Device market.
Various notable players operating in Egypt Ventricular Assist Device Market include Berlin Heart GmbH, Cardiac Assist, Inc. (LivaNova), HeartWare International, Inc., Jarvik Heart, Inc., Reliant Heart, Inc., Abbott, Sun Medical Technology Research Corp., Syncardia System, Inc., Thoratec Corporation and Abiomed among others..

The Egypt Ventricular Assist Device market has been segmented on the basis of Application, Type and Design Segmentation. Based on Application type, the market comprises of Bridge-to-transplant (BTT) Therapy, Destination Therapy and Bridge-to-recovery (BTR) Therapy. The Product type includes Left Ventricular, Right Ventricular and Biventricular Assist Device.

The research report “Egypt Ventricular Assist Device Market” provides in-depth analysis of the Ventricular Assist Device market, Egypt, based on application type, product type and design type for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for Ventricular Assist Device Market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

Key questions answered in this research report:

• • At what pace is the Ventricular Assist Device Market growing worldwide? What will be the growth trend in future?
  • What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the coming years?
  • What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in Egypt Robotic Surgical market?
  • What are the various application areas and how they are poised to grow?